INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,801 | -17.5% | 12,329 | -5.4% | 0.00% | – |
Q2 2023 | $5,820 | -48.1% | 13,029 | -4.7% | 0.00% | – |
Q1 2023 | $11,212 | -49.1% | 13,673 | -3.2% | 0.00% | – |
Q4 2022 | $22,041 | -60.6% | 14,129 | -56.7% | 0.00% | – |
Q3 2022 | $56,000 | +5.7% | 32,629 | +6.3% | 0.00% | – |
Q2 2022 | $53,000 | -51.4% | 30,696 | +1.0% | 0.00% | – |
Q1 2022 | $109,000 | -27.8% | 30,396 | 0.0% | 0.00% | – |
Q4 2021 | $151,000 | -41.2% | 30,396 | -15.3% | 0.00% | – |
Q3 2021 | $257,000 | -7.2% | 35,896 | +20.4% | 0.00% | – |
Q2 2021 | $277,000 | -51.2% | 29,806 | -51.3% | 0.00% | -100.0% |
Q1 2021 | $568,000 | +16.6% | 61,171 | +11.1% | 0.00% | 0.0% |
Q4 2020 | $487,000 | -37.8% | 55,037 | -18.5% | 0.00% | -50.0% |
Q3 2020 | $783,000 | +86.0% | 67,524 | +332.0% | 0.00% | +100.0% |
Q2 2020 | $421,000 | +446.8% | 15,630 | +51.1% | 0.00% | – |
Q1 2020 | $77,000 | -25.2% | 10,347 | -1.2% | 0.00% | -100.0% |
Q3 2014 | $103,000 | -33.5% | 10,475 | -27.0% | 0.00% | 0.0% |
Q2 2014 | $155,000 | – | 14,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |